การรอดชีพจากโรคมะเร็งในภาคเหนือของประเทศไทย ปี พ.ศ. 2546-2555

ĂêĆ øćÖćøøĂéßóĊ ×ĂÜēøÙöąđøÜĘ êĂŠ öúÖĎ ĀöćÖ ÝćĞ îüîñšĎðśü÷öąđøĘÜêĂŠ öúÖĎ ĀöćÖøć÷ĔĀöĔŠ îõćÙđĀîČĂðŘó.ý. 2546-2555 ĔîÖćøýċÖþćîöĚĊ Ċ ìÜĚĆ Āöé 1,826 øć÷ öÿĊ ëćîąđÿ÷Ċ ßüĊ êĉ 1,122 øć÷ (øðĎ ìĊę 19 ĒúąêćøćÜìęĊ 21) øðĎ ìęĊ 19 ÝćĞ îüîĒúąøĂš ÷úąēøÙöąđøÜĘ êŠĂöúÖĎ ĀöćÖĒ÷Öêćöøą÷ą×ĂÜēøÙ 714, 39% 212, Stage I 12% Stage II Stage III 521, 28% Stage IV Unknown 330, 18% 49, 3% êćøćÜìęĊ 21 ÝćĞ îüîĒúąøĂš ÷úąēøÙöąđøĘÜêĂŠ öúĎÖĀöćÖĔîõćÙđĀîĂČ Ē÷Öêćöøą÷ą×ĂÜēøÙĒúą ÝÜĆ ĀüĆé Province Stage I Stage II Stage III Stage IV Unknown Total Chiang Mai 166 (Ŝş%) 78 (Ś2%) 54 (ř5%) 45 (13%) 12 (3%) 355 (řŘŘ%) Lamphun 24 (16%) 32 (22) 8 (5%) 15 (10%) 67 (46%) 146 (řŘŘ%) Lampang 41 (Ś1%) 35 (18%) 12 (6%) 61 (32%) 42 (22%) 191 (řŘŘ%) Phitsanulok 24 (ř1%) 25 (11%) 17 (8%) 29 (13%) 124 (57%) 219 (řŘŘ%) Phrae 18 (28%) 5 (8%) 1 (2%) 12 (19%) 29 (Ŝ5%) 65 (řŘŘ%) Chiang Rai 24 (15%) 7 (5%) 7 (5%) 27 (17%) 92 (59%) 157 (řŘŘ%) ĂĆêøćÖćøøĂéßóĊ ×ĂÜēøÙöąđøÜĘ êĂŠ öúĎÖĀöćÖĒ÷Öêćöøą÷ą×ĂÜēøÙ ĂêĆ øćøĂéßĊóĒ÷Öêćöøą÷ą×ĂÜēøÙöąđøĘÜêŠĂöúĎÖĀöćÖßüŠ ÜðóŘ .ý. 2546-2555 ñúÖćøýÖċ þć ÙøĆÜĚ îüĊĚ ĉđÙøćąĀ׍ Ăš öĎúēé÷Ĕßך Ăš öúĎ ìąđï÷Ċ îöąđøÜĘ øąéïĆ ðøąßćÖø×ĂÜÝÜĆ ĀüéĆ đßĊ÷ÜĔĀöŠ úćĞ ðćÜ úćĞ óîĎ Ēúąóþĉ èēč úÖàÜęċ öĊÖćøøüïøüö×Ăš öĎúøą÷ą×ĂÜēøÙÙøïëüš î (êćøćÜìęĊ 22) éĆÜîĚĊ - ĂĆêøćøĂéßĊóēøÙöąđøĘÜêĂŠ öúĎÖĀöćÖĔîõćÙđĀîČĂēé÷øüöìÖč øą÷ą×ĂÜēøÙ öĂĊ êĆ øćøĂéßóĊ ìęĊ 40 การรอดชพี จากโรคมะเร็งในภาคเหนือของประเทศไทย ปพ.ศ. 2546-2555

1 ðŘ, 3 ðŘ Ēúą 5 ðŘ Ă÷ĎŠĔîߊüÜøšĂ÷úą 84-93, 65-74 Ēúą 54-68 êćöúćĞ éïĆ - ĂêĆ øćøĂéßóĊ ēøÙöąđøĘÜêŠĂöúĎÖĀöćÖĔîõćÙđĀîĂČ Ē÷Öêćöøą÷ą×ĂÜēøÙ éĆÜîĊĚ øą÷ąìĊę 1 öĊ ĂêĆ øćøĂéßóĊ ìĊę 1 ðŘ, 3 ðŘ Ēúą 5 ðŘ đìŠćÖïĆ øĂš ÷úą 98, 91 Ēúą 86 êćöúĞćéïĆ øą÷ąìĊę 2 öĂĊ êĆ øćøĂéßóĊ ìęĊ 1 ðŘ, 3 ðŘ Ēúą 5 ðŘ Ă÷ĎŠĔîߊüÜøšĂ÷úą 90-95, 69-76 Ēúą 57-68 êćöúĞćéĆï øą÷ąìĊę 4 öĊĂĆêøćøĂé ßóĊ ìęĊ 1 ð,Ř 3 ðŘ Ēúą 5 ðŘ Ă÷ŠĔĎ îߊüÜøšĂ÷úą 70-80, 36-44 Ēúą 54-68 êćöúćĞ éĆï êćøćÜìĊę 22 ĂêĆ øćøĂéßóĊ ēøÙöąđøÜĘ êĂŠ öúÖĎ ĀöćÖĔîõćÙđĀîĂČ Ē÷Öêćöøą÷ą×ĂÜēøÙĒúąÝÜĆ ĀüéĆ ðóŘ .ý. 2546-2555 (Relative survival of prostate cancer, 2003-2012) ŚŘŘś-ŚŘřŚ Stage I Stage II Stage III Stage IV All stage Chiang Mai 73.59 89.07 35.39 69.11 1-year 98.10 93.54 NA 30.48 62.11 3-year 90.90 76.24 NA 79.45 93.23 38.62 73.63 5-year 86.28 67.83 NA 38.57 67.97 Lamphun 71.01 84.75 40.36 64.60 1-year NA 95.38 NA 26.14 53.88 3-year NA 68.77 NA 69.47 83.55 44.21 67.01 5-year NA 67.78 NA 33.44 56.13 Lampang 1-year NA 90.45 NA 3-year NA 70.61 NA 5-year NA 57.47 NA Phitsanulok 1-year NA NA NA 3-year NA NA NA 5-year NA NA NA NA: ĕööŠ ×Ċ Ăš öúĎ ĀøČĂךĂöúĎ ĕöŠÙøïëüš î การรอดชพี จากโรคมะเรง็ ในภาคเหนือของประเทศไทย ปพ.ศ. 2546-2555 41

ïøøèćîčÖøö 1. World Health Organization. (2009). Cancer. retrieved from ttp://www.who.int/ cancer/en/. 2. ÿĞćîÖĆ îē÷ïć÷Ēúą÷čìíýćÿêøŤ ÖøąìøüÜÿćíćøèÿ×č . (2550). ÝĞćîüîĒúąĂĆêøćêć÷êŠĂ ðøąßćÖø100,000 Ùî ÝĞćĒîÖêćöđóýĒúąÿćđĀê.č Retrieved January 19, 2009, from http://bps. ops.moph.go.th/2.3.2-50.pdf. 3. Khuhaprema T, Attasara P, Sriplung H, Wiangnon S, Sumitsawan Y, Sangrajrang S. Cancer in Thailand Vol.VI 2004-2006. Bangkok; 2012. 4. Khuhaprema T, Srivatanakul P, Sriplung H, Wiangnon S, Sumitsawan Y, Attasara P. Cancer In Thailand Vol.V. Bangkok; 2010. 5. ÿöđÖĊ÷øêĉ úúĉêüÜýć, éúÿč× óÜþŤîÖĉ ø, ÖćâÝîć éćüðøąđÿøĉå, ìøÜóú ýøÿĊ ×č ē×, Ăéč öúĆÖþèŤ đÝîóćèĉß÷,Ť üĉđßĊ÷øøĆêîŤ ÝĞćîÜüìĉ ÷Ť ĒúąÙèą. (2557). Ăïč ĆêÖĉ ćøèēŤ øÙöąđøÜĘ ĔîõćÙđĀîČĂ×ĂÜ ðøąđìýĕì÷ðŘó.ý. 2551-2555. ēøÜó÷ćïćúöąđøĘÜúĞćðćÜ ÖøöÖćøĒóì÷Ť 6. Raunroadrung, N., Daoprasert, K., Srisukho, S., Phonglaohaphan, T., Sriplung, H., Pongnikorn, S. (2004) Cancer Incidence in Northern Thailand, 2003-2007, Lampang, Thailand. 7. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA: A Cancer Journal Clinicians. 2005; 55; 74–108. 8. Chang S, Long S R, Kutikova L, Bowman L, Finley D, Crown W H, Bennett C L. Estimating the Cost of Cancer: Results on the Basis of Claims Data Analyses for Cancer Patients Diagnosed With Seven Types of Cancer During 1999 to 2000. Journal of clinical oncology; 2004; 22 (7), 3524-3530. 9. ÿĞćîĆÖÜćîÿëĉêĉĒĀŠÜßćêĉ. (2555). ÿĞćöąēîðøąßćÖøĒúąđÙĀąðŘó.ý. 2553: õćÙđĀîČĂ. ÿćĞ îÖĆ Üćîÿëêĉ Ēĉ ĀÜŠ ßćêĉ ÖøąìøüÜđìÙēîēú÷ĊÿćøÿîđìýĒúąÖćøÿČęĂÿćø 10. Fritz AG, Percy C, Jack A, et al, eds. International Classifi cation of Diseases for Oncology (ICD-O), 3rd edn. Geneva: World Health Organization, 2000. 11. Esteve J, Benhamou E, Raymond L, World Health Organization. Statistical methods in cancer research. Lyon: International agency for research on cancer; 1994. 12. Coleman MP, Quaresma M, Berrino F, the CONCORD Working Group Cancer survival in five continents: a worldwide population-based study (CONCORD) Lancet Oncol. 2008;9:730–756 42 การรอดชีพจากโรคมะเร็งในภาคเหนอื ของประเทศไทย ปพ .ศ. 2546-2555

13. Berrino F, De Angelis R, Sant M, the EUROCARE Working Group Survival for eight 43 major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study. Lancet Oncol.2007;8:773–783. 14. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, et al. (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995– 2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377: 127–138 15. ĀĆßßć ýøĊðúĆęÜ.(2553). üĉđÙøćąĀŤÙčèõćóךĂöĎúöąđøĘÜĒúąýċÖþćÿëćîÖćøèŤēøÙöąđøĘÜĒúą ÙüćöÿĆöóĆîíÖŤ ĆïĒîüēîšöĒúąÖćøÖøąÝć÷×ĂÜðÝŦ Ý÷Ć đÿĊę÷ÜÝćÖĒĀúŠÜ×Ăš öúĎ êŠćÜė Retrieved January 10, 2016, from http://www.hiso.or.th/hiso/picture/reportHealth/ n_ report1.pdf 16. Gondos A, Holleczek B, Arndt V, Stegmaier C, Ziegler H, Brenner H. Trends in population based cancer survival in Germany: to what extent does progress reach older patients. Ann Oncol. 2007 Jul;18(7):1253-9. 17. Lim GH, Wong CS, Chow KY, Bhalla V, Chia KS. Trends in long-term cancer survival in Singapore: 1968-2002. Annals of the Academy of Medicine, Singapore; 2009; 38(2),99-7. 18. Tryggvadóttir L, Gislum M, Bray F, Klint A, Hakulinen T, Storm HH, et al. Trends in the survival of patients diagnosed with breast cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol. 2010 Jun;49(5):624–31. 19. Holleczek B, Brenner H. Trends of population-based breast cancer survival in Germany and the US: decreasing discrepancies, but persistent survival gap of elderly patients in Germany. BMC Cancer. 2012;12:317. 20. Daoprasert K, Pongnikorn D, Lalitwongsa S, Ponglaohaphan T. Cancer Survival Trends in Lampang, Thailand 1988-2007. Lampang; 2012. 21. Ederer F, Axtell LM, Cutler SJ. The relative survival: a statistical methodology. Natl Cancer Inst Monogr 1961; 6: 101–21. 22. Elandt-Johnson RC, Johnson NL. Survival models and data analysis (Wiley series in probability and mathematical statistics). Indianapolis: John Wiley & Sons, 1980. 23. Ewbank DC, Gomez de Leon JC, Stoto MA. A reducible fourparameter system of model life tables. Popul Stud (Camb) 1983; 37: 105–29. 24. Corazziari I, Quinn MJ, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004; 40: 2307–16. การรอดชีพจากโรคมะเร็งในภาคเหนือของประเทศไทย ปพ .ศ. 2546-2555

44 การรอดชพี จากโรคมะเรง็ ในภาคเหนอื ของประเทศไทย ปพ .ศ. 2546-2555